home / openregs / legislation

legislation: 97-s-823

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
97-s-823 97 s 823 A bill to provide for the payment of losses incurred as a result of the ban on the use of the chemical Tris in apparel, in fabric, yarn, or fiber, and for other purposes. Law 1981-03-27 1982-12-30 Became Public Law No: 97-395. Senate Sen. Thurmond, Strom [R-SC] SC R T000254 8 (Measure passed House, amended) Grants the Court of Claims jurisdiction over claims against the United States for losses sustained by producers, processors, manufacturers, distributors, or other persons resulting from the ban on children's sleepwear containing Tris phosphate. Enumerates factors to be considered by the court in determining the validity of claims. Prohibits any payments under this Act until such time as the claimant produces proof of the proper disposal of such goods. States that the amount of losses shall not include lost profits, distress sale proceeds, attorney fees, or interest on losses. Sets forth the measure of losses for producers, converters, manufacturers, distributors, and retailers of Tris-treated sleepwear or the fabric yarn, or fiber. Prohibits class action claims. Subrogates the United States to a successful claimants' rights to recover losses. Bars claims under this Act unless begun within two years of enactment. Prohibits recovery by any claimant who knowingly exported Tris-treated products after June 14, 1978. Provides for the offset of any judgment obtained by a claimant against any unpaid loans owed to the Small Business Administration. States that nothing in this Act constitutes an admission by the United States of liability for any personal injuries resulting from the use of Tris-treated products. 2026-01-07T14:44:51Z  

Links from other tables

  • 33 rows from bill_id in legislation_actions
  • 9 rows from bill_id in legislation_subjects
  • 8 rows from bill_id in legislation_cosponsors
  • 0 rows from bill_id in cbo_cost_estimates
Powered by Datasette · Queries took 31.976ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API